Results 181 to 190 of about 50,860 (258)

Pharmacotherapy Risks in Rare Genetic Diseases: Cross-Referencing ACMG Secondary Findings v3.2 List With Clinical Databases. [PDF]

Clin Transl Sci
Allen JD, Duong BQ, Brady J, Arn P.
europepmc   +1 more source

Beta 2 adrenergic receptor agonists as a treatment for metabolic dysfunction-associated steatohepatitis (MASH). [PDF]

NPJ Metab Health Dis
Winkler BS, Stayer KM, Rao AK, Arif E, Mendenhall TT, Thomas KL, Driggers KR, Zuo X, Fitzgibbon W, Deng P, Su Y, Dang Y, Gerges M, Kagan D, Pasham V, Wolf B, Rockey DC, Hartman JH, Lipschutz JH.   +18 more
europepmc   +1 more source

Long-acting β₂ agonist (LABA) with a long-acting muscarinic receptor antagonist (LAMA) promotes human airway smooth muscle (HASM) relaxation and circumvents β₂ adrenergic receptor tachyphylaxis. [PDF]

Respir Res
Jude J, Karmacharya N, Sherpa RT, O'Riordan TG, Koziol-White CJ, Panettieri RAJ.   +5 more
europepmc   +1 more source

Emerging opportunities in ROP therapy: from inhibiting pathological vessel growth to promoting physiological vascularization. [PDF]

Front Med (Lausanne)
Filippi L, Pini A, Bagnoli P, Dal Monte M, Cammalleri M.   +4 more
europepmc   +1 more source

Biased Orthosteric Agonism and Allosteric Modulation: Emerging Strategies for Developing New Class of β-Agonists for Obstructive Airway Diseases. [PDF]

Am J Respir Cell Mol Biol
Shah SD, Deshpande DA.
europepmc   +1 more source

Modification of the myometrial relaxing effect of nifedipine in vitro and in vivo [PDF]

, 2011
Hajagos-Tóth, Judit
core  

LABA in patients with stage I COPD and mild sleep apnea syndrome: a pilot study

Open Medicine, 2011
Kopitovic Ivan, Kojicic Marija, Drvenica Mirjana, Ilic Miroslav   +3 more
doaj   +1 more source

Recognising and managing albuterol-induced lactic acidosis. [PDF]

BMJ Case Rep
Baddam S, Muttineni S.
europepmc   +1 more source

Adrenergic signaling during parasitic infections. [PDF]

Front Immunol
Gardias P, Bąska P.
europepmc   +1 more source